Cited by 4Sexual Differentiation and DisordersNeuroendocrine regulation and behaviorGenetics and Neurodevelopmental Disorders

Excess Neonatal Testosterone Causes Male-Specific Social and Fear Memory Deficits in Wild-Type Mice

Open access
Quiñones-Labernik, Pravda, Blocklinger, Kelsey L., Bruce, Matthew R., Hagan, Emily, Preuschl, Danielle, Tesar, Charlotte, Ferri, Sarah L.·2025·eneuro

Published version of a preprint

Abstract

Neurodevelopmental disorders disproportionately affect males compared with females. The biological mechanisms of this male susceptibility or female protection have not been identified. There is evidence that fetal/neonatal gonadal hormones, which play a pivotal role in many aspects of development, may contribute. Here, we investigate the effects of excess testosterone (T) during a critical period of sex-specific brain organization on social approach and fear learning behaviors in C57BL/6J wild-type mice. Male, but not female, mice treated with T on the day of birth (Postnatal Day 0; PN0) exhibited decreased social approach as juveniles and decreased contextual fear memory as adults, compared with vehicle (veh)-treated controls. These deficits were not driven by anxiety-like behavior or changes in locomotion or body weight. Mice treated with the same dose of T on PN18, which is outside of the critical period of brain masculinization, did not demonstrate impairments compared with the veh group. These findings indicate that excess T during a critical period of early development, but not shortly after, induces long-term deficits relevant to the male sex bias in neurodevelopmental disorders.

AI snapshot

Written from the paper’s full text.

TL;DR

A single neonatal testosterone propionate injection (100 μg) on postnatal day 0, but not postnatal day 18, caused male-specific decreases in juvenile social approach and adult contextual fear memory in C57BL/6J wild-type mice, with no effects in females. These behavioral deficits were not explained by body weight, locomotion, or anxiety-like behavior.

Key findings

  • PN0 testosterone-treated males had a lower social preference index in the choice phase than Males+Veh, Females+Veh, and Females+T (p=0.013, 0.039, and 0.038, respectively); two-way ANOVA showed a main effect of treatment (F(1,65)=5.743, p=0.019, η2=0.073) and a sex × treatment trend (F(1,65)=3.827, p=0.055).
  • PN0 testosterone-treated males showed lower 24-h contextual fear freezing than Males+Veh, Females+Veh, and Females+T (p=0.029, 0.034, and 0.035, respectively); two-way ANOVA showed main effects of sex (F(1,40)=4.514, p=0.040), treatment (F(1,40)=4.310, p=0.044), and interaction (F(1,40)=4.269, p=0.045).
  • The deficits were not driven by anxiety-like behavior, locomotion, or body weight: elevated zero maze distance and open-arm time showed no significant effects, social approach distance traveled showed no significant effects, and no significant testosterone-driven weight differences within sexes were found at any age.
  • The same testosterone dose on PN18 did not impair social approach or contextual fear memory; for example, choice-phase preference index showed no treatment effect (F(1,39)=0.001, p=0.971), and 24-h fear freezing showed no treatment effect (F(1,47)=0.605, p=0.441).

Methods

  • C57BL/6J mice were used; litters were randomly assigned to testosterone propionate (100 μg in 20 μl sesame oil) or vehicle (20 μl sesame oil) subcutaneously on PN0 or PN18. A total of 205 mice were used for behavioral testing, with 21 excluded; gonadectomized A/J mice served as social stimuli.
  • Social approach was tested at PN28–32 in a three-chamber arena with 10-min habituation and choice phases and a preference index; contextual fear conditioning was tested at PN53–64 with a single 1.5 mA, 2-s footshock and a 24-h memory test. Separate cohorts were used for weight measurement and elevated zero maze.
  • Analyses used GraphPad Prism 9: two-way ANOVA with sex and treatment as main effects plus sex × treatment interaction, Tukey post hoc tests, repeated-measures three-way ANOVA for weight, p<0.05, and eta squared for effect sizes.

Limitations

  • Stated: the study used a single moderate testosterone dose; entire litters received the same treatment and same-treatment mice were housed together; mechanisms were not identified; human translation is limited by ethical constraints and unknown relationships between blood/brain testosterone and accessible samples; the manipulation is not presented as a model of any specific disorder.
  • Evident: no direct measurements of testosterone levels, receptor pathways, or brain circuits are reported; only one mouse strain and two treatment time points were tested; some PN0 mice underwent social testing before fear conditioning, so testing-order effects are not ruled out.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1523/eneuro.0020-25.2025

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

49 tests recomputed · 2 with the reported and recomputed p on opposite sides of .05

Claims the paper makes

10 of 25 cited sources checked · 4 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    Males exposed to increased levels of steroidogenic factors in amniotic fluid are more likely to be diagnosed with ASD.

    “There is evidence that males exposed to increased levels of steroidogenic factors in amniotic fluid, likely indicating fetal origin, are more likely to be diagnosed with ASD (Baron-Cohen et al., 2015).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Baron-Cohen et al., 2015 source
  • Study design and conductcitation

    Vehicle-treated mice exhibited behavior statistically equivalent to historical never-injected control mice for social preference at ~PN30 and 24 hr fear memory at ~PN60.

    “veh-treated mice exhibited behavior statistically equivalent to historical data of ours with mice that were undisturbed as neonates (no neonatal injection)”
    • Also stated in: § Discussion · plain
      “both social preference indices at ~PN30 and 24 hr fear memory results at ~PN60 were comparable between mice administered veh and never-injected control mice we have collected over various experiments”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites Ferri et al., 2021 source

      The Results sections compare Pcdh10 mutant mice with wild-type littermates, not vehicle-treated mice with historical never-injected controls. The copy describes 24-hour fear tests, but the passages found do not report a statistical comparison involving neonatal injections or social preference; searches for those terms did not locate one. Page numbers were not available. (LLM, conf=0.75)

      Experimental — accuracy not yet measured
    • cites Ferri et al., 2020 source

      Materials and Methods (Behavior; page unavailable) describes social-approach testing at about 30 and 70 days, but not vehicle-treated or never-injected mice. The Discussion (page unavailable) compares 70-day sniffing with previously collected data from naïve mice; it does not report statistical equivalence after neonatal injections. Searches for vehicle treatment, neonatal injection, and 24-hour fear memory found no passage establishing the claimed comparison. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
    • cites Schoch et al., 2017 source

      The Methods and Materials > Behavior section describes social-approach testing at 28–32 days and a separate cohort injected with saline or d-cycloserine 30 minutes before testing. Our copy does not report a statistical comparison with historical never-injected mice, neonatal vehicle injections, or 24-hour fear memory at approximately PN60 (searched those terms and their paraphrases). (LLM, conf=0.77)

      Experimental — accuracy not yet measured
  • Findingown data

    Neonatal testosterone treatment on PN0 did not affect body weight within sexes at any age.

    “Mice that underwent treatment with neonatal testosterone had similar body weight to those treated with veh on the day of birth (Fig. 4A).”
    • Also stated in: § Social and fear memory deficits are not due to differences in body weight or anxiety-like behavior · plain
      “there were no significant differences driven by testosterone within sexes at any age.”
    Quote in the paperSubstantial claim
  • Findingown data

    Neonatal testosterone treatment on PN0 did not affect distance traveled during the social approach test in juvenile mice.

    “Neonatal testosterone treatment had no effects on distance traveled during the social approach test.”
    • Also stated in: § A single testosterone treatment on the day of birth results in male-specific social approach deficits in juveniles · plain
      “Therefore, the decrease in social approach in juvenile males treated neonatally with testosterone was not an effect of altered locomotor behavior.”
    Quote in the paperSubstantial claim
  • Findingown data

    Treatment with the same dose of testosterone on PN18 did not affect social approach in juvenile mice compared to vehicle.

    “During the choice phase of the social approach test, all groups had a similar PI; a two-way ANOVA produced no main effects of sex (F(1,39)=0.084, p=0.773, η2=0.022) or treatment (F(1,39)=0.001, p=0.971, η2=0.00003), and no interaction of the two (F(1,39)=0.120, p=0.731, η2=0.003; Fig. 5B).”
    • Also stated in: § Abstract · boosted
      “Mice treated with the same dose of testosterone on postnatal day 18 (PN18), which is outside of the critical period of brain masculinization, did not demonstrate impairments compared to the vehicle group.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. 10
  • May combine two claims. 8
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Autism Spectrum Disorder (ASD) affects males at approximately a 4 to 1 ratio compared to females.

    “For example, Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) affect males at a ~4 and ~2 to 1 ratio, respectively (Maenner et al., 2023; Yang et al., 2022).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Maenner et al., 2023 source
  • May combine two claims.

    Premisecitation

    Human male testosterone production surges mid-gestation and shortly after birth, while male rodents have highest levels several days before and after birth; females of those species are exposed to significantly lower levels of gonadal hormones during early development.

    “Human male testosterone production surges mid-gestation and shortly after birth, while male rodents have highest levels several days before and after birth. Females of those species are exposed to significantly lower levels of gonadal hormones during early development (Gillies and McArthur, 2010a; McCarthy, 2011).”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites Gillies and McArthur, 2010a

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites McCarthy, 2011 source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Many social behaviors exhibit sex differences and are sensitive to gonadal hormones and endocrine disruptors.

    “Many social behaviors exhibit sex differences and are sensitive to gonadal hormones and endocrine disruptors (Bell, 2018).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Bell, 2018 source
  • Classified as probably not a substantial claim.

    Premisecitation

    A single dose of testosterone propionate (100 μg) has been shown to masculinize a female rodent brain.

    “Testosterone propionate (Sigma; 100μg in 20 μl sesame oil, a dose previously shown to induce brain masculinization in a female rodent) (Ghahramani et al., 2014; Goel and Bale, 2013; Hisasue et al., 2010; Nakachi et al., 2015; Seney et al., 2012)”
    Quote in the paperSubstantial claim1 of 3 sources checked
    • cites Ghahramani et al., 2014 source
    • cites Goel and Bale, 2013

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites Hisasue et al., 2010 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Acquisition of conditioned fear and fear extinction is impaired in psychopathy, PTSD, anxiety, and other disorders.

    “Acquisition of conditioned fear and fear extinction is impaired in psychopathy, PTSD, anxiety, and other, disorders (VanElzakker et al., 2014; Veit et al., 2013).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites VanElzakker et al., 2014 source

      Section 5.1.2 reports abnormal fear responses during acquisition and impaired extinction in PTSD; Section 6.1 reports resistance to extinction in other anxiety disorders. The source does not establish impaired acquisition across those anxiety disorders—it reports normal acquisition in one panic-disorder study—and the passages do not address psychopathy. Page numbers are unavailable in our copy. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites Veit et al., 2013 source

      The Results and Discussion report deficient acquisition of conditioned fear responses in highly psychopathic offenders, particularly those scoring high on the affective facet. Although the Experimental design includes an extinction phase, the paper does not establish impaired fear extinction. It does not study PTSD, anxiety, or other disorders; those parts of the jointly cited sentence are not supported by Veit et al. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingown data

    In C57BL/6J wild-type mice, treatment with testosterone on the day of birth (PN0) decreased social approach in juvenile males compared to vehicle-treated controls, but not in females.

    “Male, but not female, mice treated with testosterone on the day of birth (PN0) exhibited decreased social approach as juveniles and decreased contextual fear memory as adults, compared to vehicle-treated controls.”
    • Also stated in: § A single testosterone treatment on the day of birth results in male-specific social approach deficits in juveniles · plain
      “A Tukey post hoc test indicated that males treated on PN0 with testosterone (Males + T) had significantly lower PI than Males + Veh, Females + Veh, and Females + T (p=0.013, 0.039, and 0.038, respectively; Fig. 2B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In C57BL/6J wild-type mice, treatment with testosterone on PN0 decreased contextual fear memory in adult males compared to vehicle-treated controls, but not in females.

    “Male, but not female, mice treated with testosterone on the day of birth (PN0) exhibited decreased social approach as juveniles and decreased contextual fear memory as adults, compared to vehicle-treated controls.”
    • Also stated in: § A single testosterone treatment on the day of birth results in male-specific contextual fear conditioning deficits in adults · plain
      “A Tukey post hoc test indicated that males treated on PN0 with testosterone (Males + T) had significantly lower freezing than Males + Veh, Females + Veh, and Females + T (p=0.029, 0.034, and 0.035, respectively; Fig. 3B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Neonatal testosterone treatment did not affect mortality, with comparable litter sizes between vehicle and testosterone groups (veh 6.735 ± 0.392 vs T 5.970 ± 0.388, p=0.1700).

    “Notably, neonatal testosterone treatment did not affect mortality; litter size was 6.735 ± 0.392 for veh and 5.970 ± 0.388 for T, p=0.1700.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Attention Deficit Hyperactivity Disorder (ADHD) affects males at approximately a 2 to 1 ratio compared to females.

    “For example, Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) affect males at a ~4 and ~2 to 1 ratio, respectively (Maenner et al., 2023; Yang et al., 2022).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Yang et al., 2022 source

      Checked before — its earlier verdict is held back until a new check runs.

  • May combine two claims.

    Interpretationown data

    There is a sensitive period in which excess testosterone can disrupt sex-specific neural circuits and even a brief dysregulation of testosterone levels can induce long-lasting effects.

    “Therefore, our results indicate that excess testosterone during development is not universally detrimental but there is a sensitive period in which excess testosterone can disrupt sex-specific neural circuits and even a brief dysregulation of testosterone levels can induce long-lasting effects.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Both social approach behavior and fear memory exhibit sex differences in vulnerability in early development.

    “Additionally, these findings indicate that both social approach behavior and fear memory exhibit sex differences in vulnerability in early development, which has significant implications for neurodevelopmental and neuropsychiatric disorders that affect males and females differently in terms of prevalence, presentation, or progression.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Maternal testosterone in the second trimester is associated with increased autism-relevant behaviors in male children.

    “Maternal testosterone in the second trimester is associated with increased autism-relevant behaviors in male children (Firestein et al., 2022).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Firestein et al., 2022 source
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    Litters were randomly divided into two experimental conditions: treatment with testosterone or vehicle.

    “Litters were randomly divided into two experimental conditions: treatment with testosterone (T) or vehicle (veh; see below), receiving treatment on the day of birth (PN0) or on postnatal day 18 (PN18).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    A total of 205 mice were used for behavioral testing.

    “A total of 205 mice were used for behavioral testing. Of the 205 mice, 21 were excluded due to inactivity during the testing period, excessive climbing on cylinders, or statistical outliers (>2SD from the mean).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    Experiments were conducted in accordance with IACUC policies and approved protocols, and according to ARRIVE guidelines.

    “Experiments were conducted in accordance with the [Author University] Institutional Animal Care and Use Committee (IACUC) policies and approved protocols, and according to ARRIVE guidelines.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Of the 205 mice, 21 were excluded due to inactivity during the testing period, excessive climbing on cylinders, or statistical outliers (>2SD from the mean).

    “A total of 205 mice were used for behavioral testing. Of the 205 mice, 21 were excluded due to inactivity during the testing period, excessive climbing on cylinders, or statistical outliers (>2SD from the mean).”
    Quote in the paperNot a substantial claim
16 of 16
  • The paper relies on this without support.

    The mechanisms underlying sex differences in neurodevelopmental disorders are not fully understood.

    “The mechanisms underlying these sex differences are not fully understood, but elucidating them would significantly improve risk assessment, early intervention, and targeted treatments.”
  • The paper relies on this without support.

    Hormonal dysregulation during the critical period may cause sex-specific vulnerabilities to neurodevelopmental deficits.

    “It is during the critical period that hormonal dysregulation may cause sex-specific vulnerabilities to neurodevelopmental deficits.”
  • The paper relies on this without support.

    The effects of this dose and timing of testosterone on the male brain and behavior have not been described.

    “the effects on the male brain and behavior have not been described”
3 of 3

Statistics that don’t add up

Each reported p-value recomputed from its test statistic and degrees of freedom.

  • Inconsistent p-value across alpha = .05: F(1,39)=0.105, p = .019

    Major

    The paper reports p = .019 here; recomputing from the test statistic and its degrees of freedom gives p = .748. The two fall on opposite sides of alpha = .05. The check cannot tell whether the statistic or the p-value is the misprint.

    Reported p = .019 · recomputed p = .748

  • Inconsistent p-value across alpha = .05: F(1,65)=8.17, p = .370

    Major

    The paper reports p = .37 here; recomputing from the test statistic and its degrees of freedom gives p = .006. The two fall on opposite sides of alpha = .05. The check cannot tell whether the statistic or the p-value is the misprint.

    Reported p = .37 · recomputed p = .006

2 of 2

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Doesn’t add upF(1, 65) = 8.17reported p = .37 · recomputed p = .006The two fall on opposite sides of .05

    “F(1,65)=8.17, p = .370”

  • Doesn’t add upF(1, 39) = 0.105reported p = .019 · recomputed p = .748The two fall on opposite sides of .05

    “F(1,39)=0.105, p = .019”

  • Not confirmedF(1, 34) = 3.117reported p = .087 · recomputed p = .086

    “F(1,34)=3.117, p = .087”

  • Not confirmedF(1, 34) = 2.09reported p = .158 · recomputed p = .157

    “F(1,34)=2.090, p = .158”

  • ConsistentF(1, 65) = 0.2reported p = .656 · recomputed p = .656

    “F(1,65)=0.200, p = .656”

  • ConsistentF(1, 65) = 0.034reported p = .855 · recomputed p = .854

    “F(1,65)=0.034, p = .855”

  • ConsistentF(1, 65) = 2.188reported p = .144 · recomputed p = .144

    “F(1,65)=2.188, p = .144”

  • ConsistentF(1, 65) = 5.743reported p = .019 · recomputed p = .019

    “F(1,65)=5.743, p = .019”

  • ConsistentF(1, 65) = 3.827reported p = .055 · recomputed p = .055

    “F(1,65)=3.827, p = .055”

  • ConsistentF(1, 65) = 0.355reported p = .553 · recomputed p = .553

    “F(1,65)=0.355, p = .553”

  • ConsistentF(1, 65) = 2.008reported p = .161 · recomputed p = .161

    “F(1,65)=2.008, p = .161”

  • ConsistentF(1, 65) = 2.655reported p = .108 · recomputed p = .108

    “F(1,65)=2.655, p = .108”

  • ConsistentF(1, 65) = 1.029reported p = .314 · recomputed p = .314

    “F(1,65)=1.029, p = .314”

  • ConsistentF(1, 65) = 0.823reported p = .368 · recomputed p = .368

    “F(1,65)=0.823, p = .368”

  • ConsistentF(1, 65) = 0.697reported p = .407 · recomputed p = .407

    “F(1,65)=0.697, p = .407”

  • ConsistentF(1, 40) = 0.199reported p = .658 · recomputed p = .658

    “F(1,40)=0.199, p = .658”

  • ConsistentF(1, 40) = 2.067reported p = .158 · recomputed p = .158

    “F(1,40)=2.067, p = .158”

  • ConsistentF(1, 40) = 1.372reported p = .248 · recomputed p = .248

    “F(1,40)=1.372, p = .248”

  • ConsistentF(1, 40) = 4.514reported p = .04 · recomputed p = .040

    “F(1,40)=4.514, p = .040”

  • ConsistentF(1, 40) = 4.31reported p = .044 · recomputed p = .044

    “F(1,40)=4.310, p = .044”

  • ConsistentF(1, 40) = 4.269reported p = .045 · recomputed p = .045

    “F(1,40)=4.269, p = .045”

  • ConsistentF(2, 60) = 2525reported p < .0001 · recomputed p < .001

    “F(2,60)=2525, p < .0001”

  • ConsistentF(1, 29) = 12.69reported p = .001 · recomputed p = .001

    “F(1,29)=12.69, p = .001”

  • ConsistentF(1, 29) = 7.345reported p = .011 · recomputed p = .011

    “F(1,29)=7.345, p = .011”

  • ConsistentF(8, 232) = 41.04reported p < .0001 · recomputed p < .001

    “F(8,232)=41.04, p < .0001”

  • ConsistentF(8, 232) = 4.967reported p < .0001 · recomputed p < .001

    “F(8,232)=4.967, p < .0001”

  • ConsistentF(8, 232) = 2.556reported p < .011 · recomputed p = .011

    “F(8,232)=2.556, p < .011”

  • ConsistentF(1, 29) = 0.027reported p = .871 · recomputed p = .871

    “F(1,29)=0.027, p = .871”

  • ConsistentF(1, 34) = 0.102reported p = .751 · recomputed p = .751

    “F(1,34)=0.102, p = .751”

  • ConsistentF(1, 34) = 0.012reported p = .913 · recomputed p = .913

    “F(1,34)=0.012, p = .913”

  • ConsistentF(1, 34) = 0.623reported p = .435 · recomputed p = .435

    “F(1,34)=0.623, p = .435”

  • ConsistentF(1, 34) = 0.551reported p = .463 · recomputed p = .463

    “F(1,34)=0.551, p = .463”

  • ConsistentF(1, 39) = 0.01reported p = .922 · recomputed p = .921

    “F(1,39)=0.010, p = .922”

  • ConsistentF(1, 39) = 1.28reported p = .265 · recomputed p = .265

    “F(1,39)=1.280, p = .265”

  • ConsistentF(1, 39) = 0.586reported p = .449 · recomputed p = .449

    “F(1,39)=0.586, p = .449”

  • ConsistentF(1, 39) = 0.084reported p = .773 · recomputed p = .773

    “F(1,39)=0.084, p = .773”

  • ConsistentF(1, 39) = 0.001reported p = .971 · recomputed p = .975

    “F(1,39)=0.001, p = .971”

  • ConsistentF(1, 39) = 0.12reported p = .731 · recomputed p = .731

    “F(1,39)=0.120, p = .731”

  • ConsistentF(1, 39) = 0.153reported p = .698 · recomputed p = .698

    “F(1,39)=0.153, p = .698”

  • ConsistentF(1, 39) = 0.089reported p = .767 · recomputed p = .767

    “F(1,39)=0.089, p = .767”

  • ConsistentF(1, 39) = 0.345reported p = .561 · recomputed p = .560

    “F(1,39)=0.345, p = .561”

  • ConsistentF(1, 39) = 8.207reported p = .007 · recomputed p = .007

    “F(1,39)=8.207, p = .007”

  • ConsistentF(1, 39) = 0.286reported p = .596 · recomputed p = .596

    “F(1,39)=0.286, p = .596”

  • ConsistentF(1, 47) = 3.887reported p = .055 · recomputed p = .055

    “F(1,47)=3.887, p = .055”

  • ConsistentF(1, 47) = 0.779reported p = .382 · recomputed p = .382

    “F(1,47)=0.779, p = .382”

  • ConsistentF(1, 47) = 0.081reported p = .778 · recomputed p = .777

    “F(1,47)=0.081, p = .778”

  • ConsistentF(1, 47) = 2.513reported p = .12 · recomputed p = .120

    “F(1,47)=2.513, p = .120”

  • ConsistentF(1, 47) = 0.605reported p = .441 · recomputed p = .441

    “F(1,47)=0.605, p = .441”

  • ConsistentF(1, 47) = 1.421reported p = .239 · recomputed p = .239

    “F(1,47)=1.421, p = .239”

49 of 49

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Fear-baseline interaction names a factor absent from the stated analysis

    Minor

    The Methods specify a sex × treatment interaction for these two-way ANOVAs, whereas the fear-baseline result reports a phase × sex interaction.

  • PN18 locomotion treatment effect is called nonsignificant despite p=0.019

    Minor

    The reported p-value is below the paper's stated significance threshold, but the result is described as showing no main effect of treatment.

  • Conflicting counts of PN18 mice tested only for fear conditioning

    Minor

    One Methods passage says 7 of 51 PN18-treated mice underwent only fear conditioning; another says 8 additional mice did not undergo social testing.

3 of 3

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. 10.3389/FPSYG.2022.997648/BIBTEX · DOI

Cited by

Sorted by citations

Authors
Quiñones-Labernik, P., Blocklinger, K. L., Bruce, M. R., Hagan, E., Preuschl, D., Tesar, C., & Ferri, S. L.
Affiliations
  • University of Iowa (US)
  • Temple University (US)
Venue
eneuro
Published
2025-07-07
Volume
12
Issue
8
Pages
ENEURO.0020-25.2025
ISSN
2373-2822 (ISSN-L)
OpenAlex
W4412075488
Cited by
4
References
85
Citations by year
2026: 3 · 2025: 1
FWCI
1.03
Type
journal article
Language
en
Open access
Locations
  • eNeuro (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by-nc-nd)
  • PubMed Central (submittedVersion, cc-by)
Funders
  • HHS | NIH | National Institute of Mental Health (K01 MH119540)
  • HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50 HD103556)
  • HHS | NIH | National Institute of General Medical Sciences (T32 GM144636)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
neonatal testosterone, social approach behavior, contextual fear memory, brain masculinization, critical periods of development, gonadal hormones, wild-type mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-12.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-12.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review